Are serum hormones associated with the risk of prostate cancer? Prospective results from the Massachusetts Male Aging Study

Urology

Volumn 57, Issue 5, 2001, Pages 930-935

  Mohr, Beth A ^a   Feldman, Henry A ^a   Kalish, Leslie A ^a   Longcope, Christopher ^b   McKinlay, John B ^a  

^a NEW ENGLAND RESEARCH INSTITUTES   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTANEDIOL GLUCURONIDE; ANDROSTANOLONE; ESTROGEN; HYPOPHYSIS HORMONE; THYROID HORMONE; UNCLASSIFIED DRUG;

ADULT; AGED; AGING; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CANCER RISK; CONTROLLED STUDY; HORMONE BLOOD LEVEL; HUMAN; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; RISK; STATISTICAL ANALYSIS; UNITED STATES;

ADRENAL CORTEX HORMONES; ADULT; AGED; ANDROGENS; ANDROSTANE-3,17-DIOL; ESTROGENS; FOLLOW-UP STUDIES; HUMANS; MALE; MASSACHUSETTS; MIDDLE AGED; PITUITARY HORMONES; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS; SAMPLING STUDIES;

EID: 0035030328     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(00)01116-X     Document Type: Article

References (37)

1. Cancer statistics by race and ethnicity
2. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer
3. Endogenous hormones as a major factor in human cancer
4. The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration
5. Cirrhosis and carcinoma of the prostate gland
6. Serological precursors of cancer; serum hormones and risk of subsequent prostate cancer
7. The relationship of serum dehydroepiandrosterone and its sulfate to subsequent cancer of the prostate
8. Longitudinal evaluation of serum androgen levels in men with and without prostate cancer
9. Seasonal variation in vitamin D, vitamin D-binding protein, and dehydroepiandrosterone; risk of prostate cancer in black and white men
10. Serum androgens and prostate cancer
11. Androgens in serum and the risk of prostate cancer; a nested case-control study from the Janus serum bank in Norway
12. 5-Alpha-reductase activity and prostate cancer; a case-control study using stored sera
13. Relationships of serum androgens and estrogens to prostate cancer risk; results from a prospective study in Finland
14. A prospective, population-based study of androstenedione, estrogens, and prostatic cancer
15. Prospective study of sex hormone levels and risk of prostate cancer
16. Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP
17. Prostate-specific antigen and prostatic acid phosphatase; biomolecular and physiologic characteristics
18. Androgens up-regulate the human prostate-specific antigen messenger ribonucleic acid (mRNA), but down-regulate the prostatic acid phosphatase mRNA in the LNCaP cell line
19. Serum prostate specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors
20. Androgens, estrogens and sex hormone-binding globulin in middle-aged men
21. Age, disease, and changing sex hormone levels in middle-aged men; results of the Massachusetts Male Aging Study
22. Modifiable risk factors and erectile dysfunction; can lifestyle changes modify risk?
23. Physical activity and public health; a recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine
24. Endogenous sex hormones and prostate cancer; a quantitative review of prospective studies
25. 5-Alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males
26. Review of the role of androgenic hormones in the epidemiology of benign prostatic hyperplasia and prostate cancer
27. Changing concepts of active androgens in blood
28. Androgen levels in the plasma and prostatic tissues of patients with benign hypertrophy and carcinoma of the prostate
29. 3-Alpha, 17 beta-androstanediol glucuronide in plasma; a marker of androgen action in idiopathic hirsutism
30. Production, clearance, and metabolism of testosterone in men with prostatic cancer
31. Prediagnostic serum hormones and the risk of prostate cancer
32. The free hormone hypothesis; a physiologically based mathematical model
33. Hormones and prostate cancer; where do we go from here?